Abstract
Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.
Original language | English |
---|---|
Article number | 04423 |
Pages (from-to) | 745-749 |
Number of pages | 5 |
Journal | Infection Control and Hospital Epidemiology |
Volume | 21 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1 Jan 2000 |
Externally published | Yes |
Fingerprint
Cite this
}
Should we routinely use mupirocin to prevent staphylococcal infections? / Roth, Virginia R.; Murphy, Cathryn; Perl, Trish M.; DeMaria, Alfred; Sohn, Annette H.; Sinkowitz-Cochran, Ronda L.; Jarvis, William R.
In: Infection Control and Hospital Epidemiology, Vol. 21, No. 11, 04423, 01.01.2000, p. 745-749.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Should we routinely use mupirocin to prevent staphylococcal infections?
AU - Roth, Virginia R.
AU - Murphy, Cathryn
AU - Perl, Trish M.
AU - DeMaria, Alfred
AU - Sohn, Annette H.
AU - Sinkowitz-Cochran, Ronda L.
AU - Jarvis, William R.
PY - 2000/1/1
Y1 - 2000/1/1
N2 - Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.
AB - Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.
UR - http://www.scopus.com/inward/record.url?scp=0033692834&partnerID=8YFLogxK
U2 - 10.1086/501720
DO - 10.1086/501720
M3 - Article
VL - 21
SP - 745
EP - 749
JO - Infection Control
JF - Infection Control
SN - 0899-823X
IS - 11
M1 - 04423
ER -